{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:34:33Z","timestamp":1790220873850,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The coronavirus disease 2019 (COVID-19) outbreak, caused by SARS-CoV-2, has rapidly expanded to a global pandemic. However, numbers of infected cases, deaths, and mortality rates related to COVID-19 vary from country to country. Although many studies were conducted, the reasons of these differences have not been clarified. In this study, we comprehensively investigated 12,343 SARS-CoV-2 genome sequences isolated from patients\/individuals in six geographic areas and identified a total of 1234 mutations by comparing with the reference SARS-CoV-2 sequence. Through a hierarchical clustering based on the mutant frequencies, we classified the 28 countries into three clusters showing different fatality rates of COVID-19. In correlation analyses, we identified that ORF1ab 4715L and S protein 614G variants, which are in a strong linkage disequilibrium, showed significant positive correlations with fatality rates (<jats:italic>r<\/jats:italic>\u2009=\u20090.41, <jats:italic>P<\/jats:italic>\u2009=\u20090.029 and <jats:italic>r<\/jats:italic>\u2009=\u20090.43, <jats:italic>P<\/jats:italic>\u2009=\u20090.022, respectively). We found that BCG-vaccination status significantly associated with the fatality rates as well as number of infected cases. In BCG-vaccinated countries, the frequency of the S 614G variant had a trend of association with the higher fatality rate. We also found that the frequency of several <jats:italic>HLA<\/jats:italic> alleles, including <jats:italic>HLA-A*11:01<\/jats:italic>, were significantly associated with the fatality rates, although these factors were associated with number of infected cases and not an independent factor to affect fatality rate in each country. Our findings suggest that SARS-CoV-2 mutations as well as BCG-vaccination status and a host genetic factor, <jats:italic>HLA<\/jats:italic> genotypes might affect the susceptibility to SARS-CoV-2 infection or severity of COVID-19.<\/jats:p>","DOI":"10.1038\/s10038-020-0808-9","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T17:03:47Z","timestamp":1595437427000},"page":"1075-1082","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":314,"title":["SARS-CoV-2 genomic variations associated with mortality rate of COVID-19"],"prefix":"10.1038","volume":"65","author":[{"given":"Yujiro","family":"Toyoshima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensaku","family":"Nemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9236-9061","authenticated-orcid":false,"given":"Kazuma","family":"Kiyotani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,22]]},"reference":[{"key":"808_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265\u20139.","journal-title":"Nature"},{"key":"808_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270\u20133.","journal-title":"Nature"},{"key":"808_CR3","doi-asserted-by":"publisher","first-page":"E3900","DOI":"10.1073\/pnas.1323705111","volume":"111","author":"L Subissi","year":"2014","unstructured":"Subissi L, Posthuma CC, Collet A, Zevenhoven-Dobbe JC, Gorbalenya AE, Decroly E, et al. One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities. Proc Natl Acad Sci USA. 2014;111:E3900\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"808_CR4","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","volume":"395","author":"C Wang","year":"2020","unstructured":"Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395:470\u20133.","journal-title":"Lancet"},{"key":"808_CR5","doi-asserted-by":"publisher","first-page":"30494","DOI":"10.2807\/1560-7917.ES.2017.22.13.30494","volume":"22","author":"Y Shu","year":"2017","unstructured":"Shu Y, McCauley J. GISAID: Global initiative on sharing all influenza data\u2014from vision to reality. Eur Surveill. 2017;22:30494.","journal-title":"Eur Surveill"},{"key":"808_CR6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s10038-020-0771-5","volume":"65","author":"K Kiyotani","year":"2020","unstructured":"Kiyotani K, Toyoshima Y, Nemoto K, Nakamura Y. Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2. J Hum Genet. 2020;65:569\u201375.","journal-title":"J Hum Genet"},{"key":"808_CR7","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1101\/gr.229202","volume":"12","author":"WJ Kent","year":"2002","unstructured":"Kent WJ. BLAT-the BLAST-like alignment tool. Genome Res. 2002;12:656\u201364.","journal-title":"Genome Res"},{"key":"808_CR8","first-page":"D783","volume":"48","author":"FF Gonzalez-Galarza","year":"2020","unstructured":"Gonzalez-Galarza FF, McCabe A, Santos E, Jones J, Takeshita L, Ortega-Rivera ND, et al. Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools. Nucleic Acids Res. 2020;48:D783\u20138.","journal-title":"Nucleic Acids Res"},{"key":"808_CR9","doi-asserted-by":"crossref","unstructured":"Ozdemir C, Kucuksezer UC, Tamay ZU. Is BCG vaccination affecting the spread and severity of COVID-19? Allergy. 2020;75:1824\u20137.","DOI":"10.1111\/all.14344"},{"key":"808_CR10","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.tube.2009.03.002","volume":"89","author":"N Ritz","year":"2009","unstructured":"Ritz N, Curtis N. Mapping the global use of different BCG vaccine strains. Tuberculosis. 2009;89:248\u201351.","journal-title":"Tuberculosis"},{"key":"808_CR11","doi-asserted-by":"publisher","first-page":"e1001012","DOI":"10.1371\/journal.pmed.1001012","volume":"8","author":"A Zwerling","year":"2011","unstructured":"Zwerling A, Behr MA, Verma A, Brewer TF, Menzies D, Pai M. The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med. 2011;8:e1001012.","journal-title":"PLoS Med"},{"key":"808_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","volume":"21","author":"JC Barrett","year":"2005","unstructured":"Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263\u20135.","journal-title":"Bioinformatics"},{"key":"808_CR13","doi-asserted-by":"crossref","unstructured":"Becerra-Flores M, Cardozo T. SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate. Int J Clin Pract. 2020;00:e13525.","DOI":"10.1111\/ijcp.13525"},{"key":"808_CR14","doi-asserted-by":"crossref","unstructured":"Gursel M, Gursel I. Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic? Allergy. 2020;75:1815\u20139.","DOI":"10.1111\/all.14345"},{"key":"808_CR15","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1001\/jama.2020.8189","volume":"323","author":"U Hamiel","year":"2020","unstructured":"Hamiel U, Kozer E, Youngster I. SARS-CoV-2 rates in BCG-vaccinated and unvaccinated young adults. JAMA. 2020;323:2340\u20131.","journal-title":"JAMA"},{"key":"808_CR16","doi-asserted-by":"publisher","first-page":"9241","DOI":"10.1073\/pnas.2004999117","volume":"117","author":"P Forster","year":"2020","unstructured":"Forster P, Forster L, Renfrew C, Forster M. Phylogenetic network analysis of SARS-CoV-2 genomes. Proc Natl Acad Sci USA. 2020;117:9241\u20133.","journal-title":"Proc Natl Acad Sci USA"},{"key":"808_CR17","doi-asserted-by":"publisher","first-page":"E324","DOI":"10.3390\/pathogens9050324","volume":"9","author":"T Koyama","year":"2020","unstructured":"Koyama T, Weeraratne D, Snowdon JL, Parida L. Emergence of drift variants that may affect COVID-19 vaccine development and antibody treatment. Pathogens. 2020;9:E324.","journal-title":"Pathogens"},{"key":"808_CR18","doi-asserted-by":"crossref","unstructured":"Gonzalez-Reiche AS, Hernandez MM, Sullivan MJ, Ciferri B, Alshammary H, Obla A, et al. Introductions and early spread of SARS-CoV-2 in the New York City area. Science. 2020;369:297\u2013301.","DOI":"10.1126\/science.abc1917"},{"key":"808_CR19","doi-asserted-by":"crossref","unstructured":"Deng X, Gu W, Federman S, du Plessis L, Pybus OG, Faria N, et al. Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California. Science. 2020. In press.","DOI":"10.1126\/science.abb9263"},{"key":"808_CR20","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","volume":"5","author":"M Letko","year":"2020","unstructured":"Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020;5:562\u20139.","journal-title":"Nat Microbiol"},{"key":"808_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271\u201380.e8.","journal-title":"Cell"},{"key":"808_CR22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ijid.2020.05.071","volume":"96","author":"M Eaaswarkhanth","year":"2020","unstructured":"Eaaswarkhanth M, Al Madhoun A, Al-Mulla F. Could the D614G substitution in the SARS-CoV-2 spike (S) protein be associated with higher COVID-19 mortality? Int J Infect Dis. 2020;96:459\u201360.","journal-title":"Int J Infect Dis"},{"key":"808_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-4-9","volume":"4","author":"M Lin","year":"2003","unstructured":"Lin M, Tseng HK, Trejaut JA, Lee HL, Loo JH, Chu CC, et al. Association of HLA class I with severe acute respiratory syndrome coronavirus infection. BMC Med Genet. 2003;4:9.","journal-title":"BMC Med Genet"},{"key":"808_CR24","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1086\/421523","volume":"190","author":"MH Ng","year":"2004","unstructured":"Ng MH, Lau KM, Li L, Cheng SH, Chan WY, Hui PK, et al. Association of human-leukocyte-antigen class I (B*0703) and class II (DRB1*0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome. J Infect Dis. 2004;190:515\u20138.","journal-title":"J Infect Dis"},{"key":"808_CR25","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1128\/JCM.44.2.359-365.2006","volume":"44","author":"YM Chen","year":"2006","unstructured":"Chen YM, Liang SY, Shih YP, Chen CY, Lee YM, Chang L, et al. Epidemiological and genetic correlates of severe acute respiratory syndrome coronavirus infection in the hospital with the highest nosocomial infection rate in Taiwan in 2003. J Clin Microbiol. 2006;44:359\u201365.","journal-title":"J Clin Microbiol"},{"key":"808_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4103\/1817-1737.185756","volume":"11","author":"AH Hajeer","year":"2016","unstructured":"Hajeer AH, Balkhy H, Johani S, Yousef MZ, Arabi Y. Association of human leukocyte antigen class II alleles with severe Middle East respiratory syndrome-coronavirus infection. Ann Thorac Med. 2016;11:211\u20133.","journal-title":"Ann Thorac Med"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s10038-020-0808-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-020-0808-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s10038-020-0808-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:09:18Z","timestamp":1684616958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-020-0808-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,22]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["808"],"URL":"https:\/\/doi.org\/10.1038\/s10038-020-0808-9","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,22]]},"assertion":[{"value":"9 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"YN is a stockholder and a scientific advisor of OncoTherapy Science, Inc. KK is a scientific advisor of Cancer Precision Medicine, Inc. This study is unrelated to the activity in these companies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}